505
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Association between smoking behavior patterns and chronic obstructive pulmonary disease: A long-term follow-up study among Finnish adults

, , &
Pages 598-606 | Received 13 Dec 2010, Accepted 04 Apr 2011, Published online: 10 Sep 2012

Figures & data

Table I. Formation of categories describing change in smoking patterns 1975–1981. Initial groups (on the left) were grouped together if their regression coefficients could be set equal in the regression model. Final categories are presented in the second column, and number of subjects (n) in each category in the third column.

Table II. Development of COPD, defined by regular anticholinergic medication or special reimbursement eligibility, by daily smoking patterns with number of subjects in each category, proportion of subjects affected, odds ratios (ORs), and 95% confidence intervals (95% CIs).

Table III. Hazard ratios (HRs) with 95% confidence intervals (95% CIs) for regular anticholinergic medication and special reimbursement eligibilities among different smoking patterns. Number of subjects and affected subjects in each category are presented.

Figure 1. Results of the Cox proportional hazards regression model for regular anticholinergic medication among smoking groups in 1981, with never smokers as a reference category (Ref). Data points represent hazard ratios (HRs) with 95% confidence intervals (CIs) for each smoking group. Continuous line represents the result of the trend test.

Figure 1. Results of the Cox proportional hazards regression model for regular anticholinergic medication among smoking groups in 1981, with never smokers as a reference category (Ref). Data points represent hazard ratios (HRs) with 95% confidence intervals (CIs) for each smoking group. Continuous line represents the result of the trend test.

Figure 2. Hazard ratios1 (HRs) with 95% confidence intervals (95% CIs) for regular anticholinergic medication and special reimbursement eligibilities among different smoking patterns, with never smokers as a reference group. Only HR for medication is shown if a group has no observations for special reimbursements. Heavy → light smokers, initiators, and occasional smokers not shown. Notes: 1Hazard ratios (HR) obtained from Cox proportional hazards regression model. 2Hazard ratios results were adjusted for sex, pack-years, chronic bronchitis, asthma, education, physical activity, and alcohol use. 3***P ≤ 0.001 (non-significant results have no asterisks). 4P ≤ 0.001 for special reimbursement; P value for anticholinergic medication non-significant. 5P ≤ 0.001 for anticholinergic medication; P value for special reimbursement non-significant.

Figure 2. Hazard ratios1 (HRs) with 95% confidence intervals (95% CIs) for regular anticholinergic medication and special reimbursement eligibilities among different smoking patterns, with never smokers as a reference group. Only HR for medication is shown if a group has no observations for special reimbursements. Heavy → light smokers, initiators, and occasional smokers not shown. Notes: 1Hazard ratios (HR) obtained from Cox proportional hazards regression model. 2Hazard ratios results were adjusted for sex, pack-years, chronic bronchitis, asthma, education, physical activity, and alcohol use. 3***P ≤ 0.001 (non-significant results have no asterisks). 4P ≤ 0.001 for special reimbursement; P value for anticholinergic medication non-significant. 5P ≤ 0.001 for anticholinergic medication; P value for special reimbursement non-significant.

Figure 3. Age-adjusted Nelson–Aalen cumulative hazard estimates for special reimbursement eligibilities according to 1981 smoking status.

Figure 3. Age-adjusted Nelson–Aalen cumulative hazard estimates for special reimbursement eligibilities according to 1981 smoking status.

Figure 4. Age-adjusted Nelson–Aalen cumulative hazard estimates for regular anticholinergic medication according to 1981 smoking status.

Figure 4. Age-adjusted Nelson–Aalen cumulative hazard estimates for regular anticholinergic medication according to 1981 smoking status.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.